Medical Bags Manufacturing Equipment Market Size, Trends & Growth Opportunity By Equipment Type, By Medical Bag Type, By Automation Level, By Regulatory Environment, By Region and Forecast Till 2030

Report ID : AMR1006215 | Industries : Machinery & Equipment | Published On :October 2026 | Page Count : 248

Request Sample
Ask for Customization

The global medical bags manufacturing equipment market covers the capital equipment used to produce medical bags, not the medical bags themselves as finished products.

This equipment includes thermoforming systems, medical bag forming machines, welding and sealing systems, port insertion systems, assembly automation systems, inspection systems, sterilisation preparation systems and end of line packaging equipment.

It is described here strictly as a market for manufacturing equipment and makes no efficacy, sterility-outcome, clinical-safety or patient-outcome claim about the medical bags this equipment produces.

Eight segmentation dimensions appear in this report, and the first two describe the equipment type supplied and the manufacturing technology it is built around, spanning thermoforming, film welding, RF sealing, ultrasonic sealing, laser-based processing and vision-based inspection.

The most useful commercial observation about this market is that manufacturing technology, not equipment type category alone, is the first specification decision a buyer actually makes.

Whether a bag design calls for RF sealing, ultrasonic sealing, laser-based processing or film welding determines which of the eight equipment type categories are even viable before automation level or production scale is considered.

Medical bag type produced spans eight categories, from IV solution bags and blood bags through plasma collection bags, dialysis bags, enteral feeding bags and urine collection bags to bioprocess single-use bags and pharmaceutical fluid transfer bags.

Automation level covers four categories, from manual production systems and semi-automated lines through fully automated manufacturing lines to Industry 4.0 connected production systems, and production scale spans pilot manufacturing lines, mid-volume production facilities and high-volume industrial facilities.

Regulatory environment covers four categories including FDA-compliant, EU MDR-compliant, GMP-oriented and ISO 13485-oriented manufacturing systems, and end user industry spans medical device manufacturers, pharmaceutical manufacturers, biopharmaceutical companies, contract manufacturing organisations and hospital product manufacturers.

Go-to-market model completes the segmentation across four categories, spanning direct OEM sales, EPC and turnkey projects, regional distributors and integrated production solutions providers.

This report covers medical bag manufacturing equipment supplied globally to medical device OEMs, pharmaceutical manufacturers, biopharmaceutical companies, contract manufacturing organisations and hospital product manufacturers.

It excludes the medical bags themselves as finished consumable products and general plastics processing machinery outside medical bag applications.

Buyer intelligence in the full report maps medical device OEMs, blood collection system manufacturers, IV solution manufacturers, pharmaceutical packaging producers and bioprocess equipment manufacturers across Europe, North America, Asia-Pacific, Latin America and the Middle East and Africa, including a dedicated strategic relevance assessment for Kiefel.

Competitive benchmarking metrics such as market share estimates, pricing tiers, installed base and distribution reach are covered in the full report, without disclosing proprietary competitive positioning data here.

Market Size & Growth Forecast (2026 to 2030)

The global medical bags manufacturing equipment market is estimated at approximately USD 780 Million in 2025 and is projected to reach approximately USD 1,155 Million by 2030, expanding at a compound annual growth rate of roughly 8.2 percent.

The estimate covers thermoforming, welding and sealing, port insertion, assembly automation, inspection, sterilisation preparation and end of line packaging equipment used to manufacture medical bags, and excludes the medical bags themselves as finished products.

Thermoforming systems and medical bag forming machines together account for the largest equipment type category by revenue, while assembly automation systems and inspection systems together form a fast-growing equipment type category tied to Industry 4.0 adoption.

IV solution bags and blood bags together account for the largest medical bag type category produced by installed equipment, while bioprocess single-use bags form the fastest-growing medical bag type category, tracking the pace of biopharmaceutical manufacturing investment.

Semi-automated lines account for the largest automation level category by installed base, while fully automated manufacturing lines and Industry 4.0 connected production systems together form a fast-growing automation category.

FDA-compliant and EU MDR-compliant manufacturing systems together account for the largest regulatory environment category, and ISO 13485-oriented production systems form a fast-growing category tied to global regulatory harmonisation.

Medical device manufacturers and pharmaceutical manufacturers together account for the largest end user industry category, while contract manufacturing organisations form the fastest-growing end user industry category amid rising manufacturing outsourcing.

High-volume industrial facilities account for the largest production scale category, and mid-volume production facilities form a fast-growing category tied to regional manufacturing expansion.

Direct OEM sales account for the largest go-to-market model category, and integrated production solutions providers form a fast-growing category tied to rising turnkey facility procurement.

Europe accounts for the largest regional concentration in this market, reflecting the density of established equipment engineering capacity, and Asia-Pacific forms the fastest-growing region tied to manufacturing localisation activity.

The forecast assumes global demand for IV solution bags, blood bags, dialysis bags and bioprocess single-use bags continues broadly on recent trends, and a sustained slowdown in healthcare capital spending or biopharmaceutical manufacturing investment would move the trajectory.

MetricValue
Market Size (2025)Approximately USD 780 Million
Forecast Size (2030)Approximately USD 1,155 Million
CAGR (2025-2030)Approximately 8.2%
Base Year2025
Forecast Period2026-2030 (5-year)
Scope NoteMedical bag manufacturing equipment only; excludes medical bags as finished products and general plastics processing machinery
Largest Equipment CategoryThermoforming systems and medical bag forming machines
Fastest-Growing Equipment CategoryAssembly automation systems and inspection systems
Largest Medical Bag Type CategoryIV solution bags and blood bags
Fastest-Growing Medical Bag TypeBioprocess single-use bags
Largest Regional ConcentrationEurope
Fastest-Growing RegionAsia-Pacific

 

Market Drivers

Rising global demand for IV solution bags, blood bags and dialysis bags, driving capacity expansion among medical bag converters and their equipment suppliers.

Growth of biopharmaceutical and bioprocess manufacturing, increasing demand for bioprocess single-use bag production lines and the specialised equipment required to build them.

Increasing manufacturing localisation as medical device OEMs and contract manufacturing organisations build regional production capacity closer to end markets.

Rising adoption of fully automated and Industry 4.0 connected production lines, replacing manual and semi-automated medical bag manufacturing systems.

Growth in pharmaceutical fluid transfer bag and enteral feeding bag demand, broadening equipment demand beyond the traditional IV and blood bag base.

Expansion of contract manufacturing organisation capacity, as pharmaceutical and biopharmaceutical companies increasingly outsource medical bag production rather than building in-house lines.

Rising specification of vision-based inspection and laser-based processing technologies as buyers seek tighter process control across higher-value bag types.

Growth in hospital product manufacturer investment in captive production capability, particularly in regions building healthcare manufacturing self-sufficiency.

Expansion of urine collection bag and plasma collection bag production capacity, supporting broader hospital supply and blood collection system demand.

Market Restraints

High capital cost of fully automated and Industry 4.0 connected medical bag manufacturing lines, which limits adoption among smaller regional manufacturers.

Long qualification and validation cycles under FDA, EU MDR, GMP and ISO 13485-oriented regulatory frameworks before a new production line can enter commercial use.

Dependence on the underlying demand for IV solution bags, blood bags, dialysis bags and other medical bag types, which is itself sensitive to healthcare spending cycles.

Competition between global equipment manufacturers, regional specialists and integrated production solutions providers, which fragments technical and commercial preference.

Fragmented demand across smaller regional converters, which raises the cost of serving that segment commercially relative to large multinational accounts.

Long lead times for fully automated and Industry 4.0 connected lines, which can affect a manufacturer's competitive position on accelerated facility build-out schedules.

Skilled automation and validation engineering personnel availability constraints, which can affect both new product development and ongoing customer commissioning support capacity.

Regulatory variation across FDA, EU MDR, GMP and ISO 13485-oriented jurisdictions, which requires equipment manufacturers to maintain certification and documentation packages across multiple overlapping frameworks.

Extended service and validation support expectations from pharmaceutical and biopharmaceutical buyers, which add ongoing commercial obligations beyond the initial equipment sale.

PROCUREMENT INSIGHT

Pharmaceutical and biopharmaceutical buyers increasingly qualify a new equipment manufacturer well before a specific production line order, meaning a long validation and certification qualification period functions as a genuine barrier to entry rather than a one-time onboarding cost.

 

Market Opportunities

Considerable untapped opportunity identified in the report competitive mapping.

Technology gaps and application gaps relative to the concentration of established manufacturing capacity among global equipment manufacturers.

Considerable untapped geographic opportunity identified in the report competitive mapping, particularly outside established European and North American manufacturing hubs.

Growth in Industry 4.0 connected production systems, which several manufacturers are using to differentiate their automation and validation support offering.

Underserved demand in bioprocess single-use bag and pharmaceutical fluid transfer bag production, where fewer equipment manufacturers have established deep application expertise.

Expansion of turnkey and integrated production solutions offerings, which several manufacturers are using to differentiate from standalone equipment sales.

Growth in service and maintenance revenue opportunities tied to the expanding global installed base of medical bag manufacturing lines.

Multi-technology manufacturing capability, combining thermoforming, welding and sealing and inspection systems under one supplier relationship, which reduces the number of separate qualification processes a buyer must maintain.

MARKET SHIFT

Bioprocess single-use bag and pharmaceutical fluid transfer bag production are underserved by equipment manufacturers with deep application expertise even as bioprocess single-use bags form this market's fastest-growing medical bag type category, leaving a specification-support gap that Industry 4.0 connected systems are only beginning to close.

 

Equipment Types and Manufacturing Technologies

Buyers evaluating equipment types and manufacturing technologies increasingly weigh sealing and joining technology alongside automation readiness when narrowing a shortlist, since thermoforming systems, medical bag forming machines, welding and sealing systems, port insertion systems, assembly automation systems, inspection systems, sterilisation preparation systems and end of line packaging equipment are built around film welding, RF sealing, ultrasonic sealing, laser-based processing and vision-based inspection technologies.

Medical Bag Types Produced and Automation Levels

IV solution bags, blood bags, plasma collection bags, dialysis bags, enteral feeding bags, urine collection bags, bioprocess single-use bags and pharmaceutical fluid transfer bags are produced across manual, semi-automated, fully automated and Industry 4.0 connected production systems, and this spread of bag types and automation levels shapes which equipment configuration a given production line ultimately requires.

Regulatory Environment and End User Industries

FDA-compliant, EU MDR-compliant, GMP-oriented and ISO 13485-oriented manufacturing systems serve medical device manufacturers, pharmaceutical manufacturers, biopharmaceutical companies, contract manufacturing organisations and hospital product manufacturers, a mix of regulatory environment and end user industries that varies considerably by buyer type.

Production Scale and Go-to-Market Models

Pilot manufacturing lines, mid-volume production facilities and high-volume industrial facilities are supplied through direct OEM sales, EPC and turnkey projects, regional distributors and integrated production solutions providers, and this production scale and channel pairing often determines which equipment manufacturers a buyer can realistically shortlist for a given facility.

Medical Bags Manufacturing Equipment Market, By Region

This report covers Europe, North America, Asia-Pacific, Latin America and the Middle East and Africa, reflecting where global medical bag manufacturing capacity is concentrated.

Europe accounts for the largest regional concentration in this report, covered through Germany, France, Italy, the United Kingdom, Spain, the Netherlands, Poland and the Czech Republic, with Germany receiving the deepest single-country drill-down in this report across five states, Bavaria, Baden-Wurttemberg, North Rhine-Westphalia, Lower Saxony and Hesse, and five cities, Munich, Stuttgart, Frankfurt, Cologne and Hamburg.

North America represents a steady, established regional concentration, covered through the United States, Canada and Mexico, with demand concentrated among large installed converter bases serving IV solution, blood collection and dialysis bag manufacturers.

Asia-Pacific forms the fastest-growing regional concentration in this report, covered through China, Japan, South Korea, India, Singapore, Thailand, Malaysia and Vietnam, with demand concentrated in domestic medical device and pharmaceutical packaging capacity expansion.

Latin America and the Middle East and Africa complete the regional coverage in this report, covered through Brazil, Argentina, Saudi Arabia, the United Arab Emirates and South Africa, with demand tied to healthcare manufacturing localisation investment.

Regional sizing, growth rates and country-level breakdowns are reserved for the full report rather than presented on this page.

Leading Companies

Kiefel, ILLIG, MULTIVAC, SencorpWhite, MAAC Machinery, Hudson-Sharp, W&H Group, GDM, Syntegon, SIPA, Mamata Machinery, Mitsubishi Heavy Industries, Totani Corporation and CMD Corporation are covered in the full report. An introduction to the supplier landscape by company type is available on the leading medical bag manufacturing equipment companies overview.

Beyond This Page

The full report extends well past the segmentation summarised here and into the commercial detail that shapes how medical bag manufacturing equipment supply is actually won.

Buyer intelligence maps the buyer ecosystem across medical device OEMs, blood collection system manufacturers, IV solution manufacturers, pharmaceutical packaging producers and bioprocess equipment manufacturers in full, including a dedicated strategic relevance assessment for Kiefel.

Decision-maker mapping covers vendor selection criteria, contract value bands, sales cycle length and budget ownership across corporate engineering, manufacturing operations and capital investment committees.

Competitive benchmarking compares equipment manufacturers across pricing tiers, installed base, distribution reach, service infrastructure and regulatory expertise.

The market playbook covers pricing and cost structure, compliance and regulatory shifts, customer buying behaviour and technology disruptions.

Equipment pricing benchmarks, CapEx investment analysis, procurement lifecycle and total cost of ownership analysis are covered in the full report.

Go-to-market chapters set out market entry pathways, distributor and partner mapping, regulatory approval requirements and trade fair and industry event mapping.

Company profiles cover fourteen equipment manufacturers across geographic footprint, product portfolio, certifications and research and development initiatives.

Frequently Asked Questions

Capital equipment such as thermoforming systems, welding and sealing systems, port insertion systems, assembly automation systems, inspection systems, sterilisation preparation systems and end of line packaging equipment used to produce medical bags. This report describes the category strictly as a market for manufacturing equipment, not the medical bags themselves.

The market is estimated at approximately USD 780 Million in 2025 and is projected to reach approximately USD 1,155 Million by 2030, expanding at a compound annual growth rate of roughly 8.2 percent.

Europe accounts for the largest regional concentration, reflecting the density of established equipment engineering capacity, while Asia-Pacific forms the fastest-growing region tied to manufacturing localisation activity.

Rising global demand for IV solution bags, blood bags and dialysis bags is the leading driver, alongside growth in biopharmaceutical manufacturing that is increasing demand for bioprocess single-use bag production lines.

This report covers the capital equipment used to manufacture medical bags. It does not size the medical bags themselves as finished consumable products, which are reported separately in other market categories.

Bioprocess single-use bags form the fastest-growing medical bag type category, tracking the pace of biopharmaceutical manufacturing investment more closely than any other bag type in this report.

Medical device manufacturers, pharmaceutical manufacturers, biopharmaceutical companies, contract manufacturing organisations and hospital product manufacturers are the principal buyer groups identified in this report.

FDA-compliant, EU MDR-compliant, GMP-oriented and ISO 13485-oriented manufacturing systems together govern equipment qualification and specification across the buyer base this report tracks.

Four categories are tracked: manual production systems, semi-automated lines, fully automated manufacturing lines and Industry 4.0 connected production systems, with adoption generally rising alongside bag complexity and production scale.

Inquire Before Buying Request Free Sample Ask For Discount

1. Introduction

1.1. Objective of the Study

1.2. Market Definition

1.3. Market Scope

2. Executive Summary

3. Medical Bags Market Analysis and Forecast (2026–2030)

3.1. Overview

3.2. Market Dynamics

3.3. Drivers

3.3.1. Rising Global Demand for IV Solution Bags, Blood Bags and Dialysis Bags, Driving Capacity Expansion Among Medical Bag Converters and Their Equipment Suppliers.

3.3.2. Growth of Biopharmaceutical and Bioprocess Manufacturing, Increasing Demand for Bioprocess Single-Use Bag Production Lines and the Specialised Equipment Required to Build Them.

3.3.3. Increasing Manufacturing Localisation as Medical Device OEMs and Contract Manufacturing Organisations Build Regional Production Capacity Closer to End Markets.

3.3.4. Rising Adoption of Fully Automated and Industry 4.0 Connected Production Lines, Replacing Manual and Semi-Automated Medical Bag Manufacturing Systems.

3.4. Restraints

3.4.1. High Capital Cost of Fully Automated and Industry 4.0 Connected Medical Bag Manufacturing Lines, Which Limits Adoption Among Smaller Regional Manufacturers.

3.4.2. Long Qualification and Validation Cycles Under FDA, EU MDR, GMP and ISO 13485-Oriented Regulatory Frameworks Before a New Production Line Can Enter Commercial Use.

3.4.3. Dependence on the Underlying Demand for IV Solution Bags, Blood Bags, Dialysis Bags and Other Medical Bag Types, Which Is Itself Sensitive to Healthcare Spending Cycles.

3.4.4. Competition Between Global Equipment Manufacturers, Regional Specialists and Integrated Production Solutions Providers, Which Fragments Technical and Commercial Preference.

3.5. Opportunities

3.5.1. Considerable Untapped Opportunity Identified in the Report Competitive Mapping.

3.5.2. Technology Gaps and Application Gaps Relative to the Concentration of Established Manufacturing Capacity Among Global Equipment Manufacturers.

3.5.3. Geographic White Space Opportunities Identified in the Report Competitive Mapping, Particularly Outside Established European and North American Manufacturing Hubs.

3.5.4. Growth in Industry 4.0 Connected Production Systems, Which Several Manufacturers Are Using to Differentiate Their Automation and Validation Support Offering.

3.6. Porter's Five Forces Model

3.7. Value Chain Analysis

4. Equipment Type

4.1. Thermoforming Systems

4.2. Medical Bag Forming Machines

4.3. Welding and Sealing Systems

4.4. Port Insertion Systems

4.5. Assembly Automation Systems

4.6. Inspection Systems

4.7. Sterilisation Preparation Systems

4.8. End of Line Packaging Equipment

5. Medical Bag Type Produced

5.1. IV Solution Bags

5.2. Blood Bags

5.3. Plasma Collection Bags

5.4. Dialysis Bags

5.5. Enteral Feeding Bags

5.6. Urine Collection Bags

5.7. Bioprocess Single-Use Bags

5.8. Pharmaceutical Fluid Transfer Bags

6. Automation Level

6.1. Manual Production Systems

6.2. Semi-Automated Lines

6.3. Fully Automated Manufacturing Lines

6.4. Industry 4.0 Connected Production Systems

7. Manufacturing Technology

7.1. Thermoforming

7.2. Film Welding

7.3. RF Sealing

7.4. Ultrasonic Sealing

7.5. Laser-Based Processing

7.6. Vision-Based Inspection

8. Production Scale

8.1. Pilot Manufacturing Lines

8.2. Mid-Volume Production Facilities

8.3. High-Volume Industrial Facilities

9. Regulatory Environment

9.1. FDA-Compliant Manufacturing Systems

9.2. EU MDR-Compliant Manufacturing Systems

9.3. GMP-Oriented Production Systems

9.4. ISO 13485-Oriented Production Systems

10. End User Industry

10.1. Medical Device Manufacturers

10.2. Pharmaceutical Manufacturers

10.3. Biopharmaceutical Companies

10.4. Contract Manufacturing Organisations (CMOs)

10.5. Hospital Product Manufacturers

11. Go-to-Market Model

11.1. Direct OEM Sales

11.2. EPC and Turnkey Projects

11.3. Regional Distributors

11.4. Integrated Production Solutions Providers

12. Buyer Intelligence and Demand Landscape

12.1. Buyer Segmentation

12.1.1. Medical Device OEMs

12.1.2. Blood Collection System Manufacturers

12.1.3. IV Solution Manufacturers

12.1.4. Pharmaceutical Packaging Producers

12.1.5. Bioprocess Equipment Manufacturers

12.1.6. Contract Manufacturing Organisations

12.2. Buyer Industries

12.2.1. Healthcare

12.2.2. Medical Devices

12.2.3. Pharmaceuticals

12.2.4. Biotechnology

12.2.5. Hospital Supplies

12.3. Buyer Company Types

12.3.1. Global Medical OEMs

12.3.2. Regional Manufacturers

12.3.3. Contract Manufacturers

12.3.4. Government-Owned Healthcare Producers

12.4. Country-Wise Buyer Mapping

12.4.1. Europe

12.4.2. North America

12.4.3. Asia-Pacific

12.4.4. Latin America

12.4.5. Middle East and Africa

12.5. Regional Demand Clusters

12.5.1. Germany

12.5.2. United States

12.5.3. China

12.5.4. India

12.5.5. Singapore

12.5.6. Saudi Arabia

12.6. Buyer Scale Classification

12.6.1. Large Multinationals

12.6.2. Mid-Sized Specialists

12.6.3. Emerging Regional Manufacturers

12.7. Procurement Models

12.7.1. Direct CapEx Procurement

12.7.2. Turnkey Facility Procurement

12.7.3. Multi-Vendor Production Line Procurement

12.8. Buying Triggers

12.8.1. Capacity Expansion

12.8.2. Regulatory Compliance

12.8.3. Labour Cost Reduction

12.8.4. Manufacturing Localisation

12.8.5. Product Portfolio Expansion

12.9. Decision-Maker Roles

12.9.1. Manufacturing Directors

12.9.2. Engineering Directors

12.9.3. Plant Managers

12.9.4. Operations Leaders

12.9.5. Procurement Heads

12.10. Budget Ownership

12.10.1. Corporate Engineering

12.10.2. Manufacturing Operations

12.10.3. Capital Investment Committees

12.11. Vendor Selection Criteria

12.11.1. Compliance Expertise

12.11.2. Installed Base

12.11.3. Automation Capabilities

12.11.4. Validation Support

12.11.5. Service Network

12.12. Contract Value Bands

12.12.1. Pilot Line Projects

12.12.2. Mid-Scale Production Investments

12.12.3. Full-Facility Turnkey Projects

12.13. Sales Cycle Length

12.13.1. 6-12 Months

12.13.2. 12-24 Months

12.13.3. 24+ Months

12.14. Strategic Relevance for Kiefel

12.14.1. Strategic Relevance for Kiefel

13. Global Medical Bags Manufacturing Equipment Market - Global View of Thermoforming, Welding and Sealing, Port Insertion, Assembly Automation, Inspection, Sterilisation Preparation and End of Line Packaging Systems with Spotlight on Medical Bag Types Produced, Automation Level, Manufacturing Technology, Production Scale, Regulatory Environment, End User Industry, Buyer Intelligence, Competitive Benchmarking and Growth Opportunity Analysis Market Analysis and Forecast (2026–2030)

13.1. Introduction

13.2. Market Share Analysis

13.3. Market Size and Forecast

13.4. Market Size and Forecast, By Geography

13.4.1. Europe

13.4.1.1. Market Share Analysis

13.4.1.2. Market Size and Forecast

13.4.1.3. By Product

13.4.1.4. By Technology

13.4.1.5. By Application

13.4.1.6. By Customer

13.4.1.7. Germany

13.4.1.7.1. Market Share Analysis

13.4.1.7.2. Market Size and Forecast

13.4.1.7.3. By Product

13.4.1.7.4. By Technology

13.4.1.7.5. By Application

13.4.1.7.6. By Customer

13.4.1.7.7. Bavaria

13.4.1.7.7.1. Market Share Analysis

13.4.1.7.7.2. Market Size and Forecast

13.4.1.7.7.3. By Product

13.4.1.7.7.4. By Technology

13.4.1.7.7.5. By Application

13.4.1.7.7.6. By Customer

13.4.1.7.8. Baden-Wurttemberg

13.4.1.7.8.1. Market Share Analysis

13.4.1.7.8.2. Market Size and Forecast

13.4.1.7.8.3. By Product

13.4.1.7.8.4. By Technology

13.4.1.7.8.5. By Application

13.4.1.7.8.6. By Customer

13.4.1.7.9. North Rhine-Westphalia

13.4.1.7.9.1. Market Share Analysis

13.4.1.7.9.2. Market Size and Forecast

13.4.1.7.9.3. By Product

13.4.1.7.9.4. By Technology

13.4.1.7.9.5. By Application

13.4.1.7.9.6. By Customer

13.4.1.7.10. Lower Saxony

13.4.1.7.10.1. Market Share Analysis

13.4.1.7.10.2. Market Size and Forecast

13.4.1.7.10.3. By Product

13.4.1.7.10.4. By Technology

13.4.1.7.10.5. By Application

13.4.1.7.10.6. By Customer

13.4.1.7.11. Hesse

13.4.1.7.11.1. Market Share Analysis

13.4.1.7.11.2. Market Size and Forecast

13.4.1.7.11.3. By Product

13.4.1.7.11.4. By Technology

13.4.1.7.11.5. By Application

13.4.1.7.11.6. By Customer

13.4.1.7.12. Munich

13.4.1.7.12.1. Market Share Analysis

13.4.1.7.12.2. Market Size and Forecast

13.4.1.7.12.3. By Product

13.4.1.7.12.4. By Technology

13.4.1.7.12.5. By Application

13.4.1.7.12.6. By Customer

13.4.1.7.13. Stuttgart

13.4.1.7.13.1. Market Share Analysis

13.4.1.7.13.2. Market Size and Forecast

13.4.1.7.13.3. By Product

13.4.1.7.13.4. By Technology

13.4.1.7.13.5. By Application

13.4.1.7.13.6. By Customer

13.4.1.7.14. Frankfurt

13.4.1.7.14.1. Market Share Analysis

13.4.1.7.14.2. Market Size and Forecast

13.4.1.7.14.3. By Product

13.4.1.7.14.4. By Technology

13.4.1.7.14.5. By Application

13.4.1.7.14.6. By Customer

13.4.1.7.15. Cologne

13.4.1.7.15.1. Market Share Analysis

13.4.1.7.15.2. Market Size and Forecast

13.4.1.7.15.3. By Product

13.4.1.7.15.4. By Technology

13.4.1.7.15.5. By Application

13.4.1.7.15.6. By Customer

13.4.1.7.16. Hamburg

13.4.1.7.16.1. Market Share Analysis

13.4.1.7.16.2. Market Size and Forecast

13.4.1.7.16.3. By Product

13.4.1.7.16.4. By Technology

13.4.1.7.16.5. By Application

13.4.1.7.16.6. By Customer

13.4.1.8. France

13.4.1.8.1. Market Share Analysis

13.4.1.8.2. Market Size and Forecast

13.4.1.8.3. By Product

13.4.1.8.4. By Technology

13.4.1.8.5. By Application

13.4.1.8.6. By Customer

13.4.1.9. Italy

13.4.1.9.1. Market Share Analysis

13.4.1.9.2. Market Size and Forecast

13.4.1.9.3. By Product

13.4.1.9.4. By Technology

13.4.1.9.5. By Application

13.4.1.9.6. By Customer

13.4.1.10. United Kingdom

13.4.1.10.1. Market Share Analysis

13.4.1.10.2. Market Size and Forecast

13.4.1.10.3. By Product

13.4.1.10.4. By Technology

13.4.1.10.5. By Application

13.4.1.10.6. By Customer

13.4.1.11. Spain

13.4.1.11.1. Market Share Analysis

13.4.1.11.2. Market Size and Forecast

13.4.1.11.3. By Product

13.4.1.11.4. By Technology

13.4.1.11.5. By Application

13.4.1.11.6. By Customer

13.4.1.12. Netherlands

13.4.1.12.1. Market Share Analysis

13.4.1.12.2. Market Size and Forecast

13.4.1.12.3. By Product

13.4.1.12.4. By Technology

13.4.1.12.5. By Application

13.4.1.12.6. By Customer

13.4.1.13. Poland

13.4.1.13.1. Market Share Analysis

13.4.1.13.2. Market Size and Forecast

13.4.1.13.3. By Product

13.4.1.13.4. By Technology

13.4.1.13.5. By Application

13.4.1.13.6. By Customer

13.4.1.14. Czech Republic

13.4.1.14.1. Market Share Analysis

13.4.1.14.2. Market Size and Forecast

13.4.1.14.3. By Product

13.4.1.14.4. By Technology

13.4.1.14.5. By Application

13.4.1.14.6. By Customer

13.4.2. North America

13.4.2.1. Market Share Analysis

13.4.2.2. Market Size and Forecast

13.4.2.3. By Product

13.4.2.4. By Technology

13.4.2.5. By Application

13.4.2.6. By Customer

13.4.2.7. United States

13.4.2.7.1. Market Share Analysis

13.4.2.7.2. Market Size and Forecast

13.4.2.7.3. By Product

13.4.2.7.4. By Technology

13.4.2.7.5. By Application

13.4.2.7.6. By Customer

13.4.2.8. Canada

13.4.2.8.1. Market Share Analysis

13.4.2.8.2. Market Size and Forecast

13.4.2.8.3. By Product

13.4.2.8.4. By Technology

13.4.2.8.5. By Application

13.4.2.8.6. By Customer

13.4.2.9. Mexico

13.4.2.9.1. Market Share Analysis

13.4.2.9.2. Market Size and Forecast

13.4.2.9.3. By Product

13.4.2.9.4. By Technology

13.4.2.9.5. By Application

13.4.2.9.6. By Customer

13.4.3. Asia-Pacific

13.4.3.1. Market Share Analysis

13.4.3.2. Market Size and Forecast

13.4.3.3. By Product

13.4.3.4. By Technology

13.4.3.5. By Application

13.4.3.6. By Customer

13.4.3.7. China

13.4.3.7.1. Market Share Analysis

13.4.3.7.2. Market Size and Forecast

13.4.3.7.3. By Product

13.4.3.7.4. By Technology

13.4.3.7.5. By Application

13.4.3.7.6. By Customer

13.4.3.8. Japan

13.4.3.8.1. Market Share Analysis

13.4.3.8.2. Market Size and Forecast

13.4.3.8.3. By Product

13.4.3.8.4. By Technology

13.4.3.8.5. By Application

13.4.3.8.6. By Customer

13.4.3.9. South Korea

13.4.3.9.1. Market Share Analysis

13.4.3.9.2. Market Size and Forecast

13.4.3.9.3. By Product

13.4.3.9.4. By Technology

13.4.3.9.5. By Application

13.4.3.9.6. By Customer

13.4.3.10. India

13.4.3.10.1. Market Share Analysis

13.4.3.10.2. Market Size and Forecast

13.4.3.10.3. By Product

13.4.3.10.4. By Technology

13.4.3.10.5. By Application

13.4.3.10.6. By Customer

13.4.3.11. Singapore

13.4.3.11.1. Market Share Analysis

13.4.3.11.2. Market Size and Forecast

13.4.3.11.3. By Product

13.4.3.11.4. By Technology

13.4.3.11.5. By Application

13.4.3.11.6. By Customer

13.4.3.12. Thailand

13.4.3.12.1. Market Share Analysis

13.4.3.12.2. Market Size and Forecast

13.4.3.12.3. By Product

13.4.3.12.4. By Technology

13.4.3.12.5. By Application

13.4.3.12.6. By Customer

13.4.3.13. Malaysia

13.4.3.13.1. Market Share Analysis

13.4.3.13.2. Market Size and Forecast

13.4.3.13.3. By Product

13.4.3.13.4. By Technology

13.4.3.13.5. By Application

13.4.3.13.6. By Customer

13.4.3.14. Vietnam

13.4.3.14.1. Market Share Analysis

13.4.3.14.2. Market Size and Forecast

13.4.3.14.3. By Product

13.4.3.14.4. By Technology

13.4.3.14.5. By Application

13.4.3.14.6. By Customer

13.4.4. Latin America

13.4.4.1. Market Share Analysis

13.4.4.2. Market Size and Forecast

13.4.4.3. By Product

13.4.4.4. By Technology

13.4.4.5. By Application

13.4.4.6. By Customer

13.4.4.7. Brazil

13.4.4.7.1. Market Share Analysis

13.4.4.7.2. Market Size and Forecast

13.4.4.7.3. By Product

13.4.4.7.4. By Technology

13.4.4.7.5. By Application

13.4.4.7.6. By Customer

13.4.4.8. Argentina

13.4.4.8.1. Market Share Analysis

13.4.4.8.2. Market Size and Forecast

13.4.4.8.3. By Product

13.4.4.8.4. By Technology

13.4.4.8.5. By Application

13.4.4.8.6. By Customer

13.4.5. Middle East and Africa

13.4.5.1. Market Share Analysis

13.4.5.2. Market Size and Forecast

13.4.5.3. By Product

13.4.5.4. By Technology

13.4.5.5. By Application

13.4.5.6. By Customer

13.4.5.7. Saudi Arabia

13.4.5.7.1. Market Share Analysis

13.4.5.7.2. Market Size and Forecast

13.4.5.7.3. By Product

13.4.5.7.4. By Technology

13.4.5.7.5. By Application

13.4.5.7.6. By Customer

13.4.5.8. UAE

13.4.5.8.1. Market Share Analysis

13.4.5.8.2. Market Size and Forecast

13.4.5.8.3. By Product

13.4.5.8.4. By Technology

13.4.5.8.5. By Application

13.4.5.8.6. By Customer

13.4.5.9. South Africa

13.4.5.9.1. Market Share Analysis

13.4.5.9.2. Market Size and Forecast

13.4.5.9.3. By Product

13.4.5.9.4. By Technology

13.4.5.9.5. By Application

13.4.5.9.6. By Customer

14. Competition Analysis

14.1. Market Positioning Overview

14.1.1. Global vs Regional Positioning

14.1.2. Pricing and Value Proposition Analysis

14.1.3. Target Customer Analysis

14.1.4. Technology Differentiation Assessment

14.2. Competitive Benchmarking Metrics

14.2.1. Market Share Estimates

14.2.2. Pricing Tiers

14.2.3. Installed Base

14.2.4. Distribution Reach

14.2.5. Service Infrastructure

14.2.6. Regulatory Expertise

14.2.7. Automation Capabilities

14.2.8. Innovation Intensity

14.3. Strategic Moves

14.3.1. Acquisitions

14.3.2. Strategic Partnerships

14.3.3. Product Launches

14.3.4. Manufacturing Expansions

14.3.5. Digitalisation Investments

14.4. Competitive Mapping & Gaps

14.4.1. Technology Gaps

14.4.2. Application Gaps

14.4.3. Considerable Untapped Geographic Opportunity

14.4.4. Service Differentiation Opportunities

14.4.5. Automation Upgrade Opportunities

15. Company Profiles

15.1. Kiefel

15.1.1. Overview

15.1.2. Geographic Footprint

15.1.3. Product Portfolio

15.1.4. Target Customer Segments

15.1.5. Distribution Strategy

15.1.6. Financial Overview

15.1.7. Certifications

15.1.8. Partnerships

15.1.9. Research and Development Initiatives

15.1.10. Recent Developments

15.1.11. SWOT Snapshot

15.2. ILLIG

15.2.1. Overview

15.2.2. Geographic Footprint

15.2.3. Product Portfolio

15.2.4. Target Customer Segments

15.2.5. Distribution Strategy

15.2.6. Financial Overview

15.2.7. Certifications

15.2.8. Partnerships

15.2.9. Research and Development Initiatives

15.2.10. Recent Developments

15.2.11. SWOT Snapshot

15.3. MULTIVAC

15.3.1. Overview

15.3.2. Geographic Footprint

15.3.3. Product Portfolio

15.3.4. Target Customer Segments

15.3.5. Distribution Strategy

15.3.6. Financial Overview

15.3.7. Certifications

15.3.8. Partnerships

15.3.9. Research and Development Initiatives

15.3.10. Recent Developments

15.3.11. SWOT Snapshot

15.4. SencorpWhite

15.4.1. Overview

15.4.2. Geographic Footprint

15.4.3. Product Portfolio

15.4.4. Target Customer Segments

15.4.5. Distribution Strategy

15.4.6. Financial Overview

15.4.7. Certifications

15.4.8. Partnerships

15.4.9. Research and Development Initiatives

15.4.10. Recent Developments

15.4.11. SWOT Snapshot

15.5. MAAC Machinery

15.5.1. Overview

15.5.2. Geographic Footprint

15.5.3. Product Portfolio

15.5.4. Target Customer Segments

15.5.5. Distribution Strategy

15.5.6. Financial Overview

15.5.7. Certifications

15.5.8. Partnerships

15.5.9. Research and Development Initiatives

15.5.10. Recent Developments

15.5.11. SWOT Snapshot

15.6. Hudson-Sharp

15.6.1. Overview

15.6.2. Geographic Footprint

15.6.3. Product Portfolio

15.6.4. Target Customer Segments

15.6.5. Distribution Strategy

15.6.6. Financial Overview

15.6.7. Certifications

15.6.8. Partnerships

15.6.9. Research and Development Initiatives

15.6.10. Recent Developments

15.6.11. SWOT Snapshot

15.7. W&H Group

15.7.1. Overview

15.7.2. Geographic Footprint

15.7.3. Product Portfolio

15.7.4. Target Customer Segments

15.7.5. Distribution Strategy

15.7.6. Financial Overview

15.7.7. Certifications

15.7.8. Partnerships

15.7.9. Research and Development Initiatives

15.7.10. Recent Developments

15.7.11. SWOT Snapshot

15.8. GDM

15.8.1. Overview

15.8.2. Geographic Footprint

15.8.3. Product Portfolio

15.8.4. Target Customer Segments

15.8.5. Distribution Strategy

15.8.6. Financial Overview

15.8.7. Certifications

15.8.8. Partnerships

15.8.9. Research and Development Initiatives

15.8.10. Recent Developments

15.8.11. SWOT Snapshot

15.9. Syntegon

15.9.1. Overview

15.9.2. Geographic Footprint

15.9.3. Product Portfolio

15.9.4. Target Customer Segments

15.9.5. Distribution Strategy

15.9.6. Financial Overview

15.9.7. Certifications

15.9.8. Partnerships

15.9.9. Research and Development Initiatives

15.9.10. Recent Developments

15.9.11. SWOT Snapshot

15.10. SIPA

15.10.1. Overview

15.10.2. Geographic Footprint

15.10.3. Product Portfolio

15.10.4. Target Customer Segments

15.10.5. Distribution Strategy

15.10.6. Financial Overview

15.10.7. Certifications

15.10.8. Partnerships

15.10.9. Research and Development Initiatives

15.10.10. Recent Developments

15.10.11. SWOT Snapshot

15.11. Mamata Machinery

15.11.1. Overview

15.11.2. Geographic Footprint

15.11.3. Product Portfolio

15.11.4. Target Customer Segments

15.11.5. Distribution Strategy

15.11.6. Financial Overview

15.11.7. Certifications

15.11.8. Partnerships

15.11.9. Research and Development Initiatives

15.11.10. Recent Developments

15.11.11. SWOT Snapshot

15.12. Mitsubishi Heavy Industries

15.12.1. Overview

15.12.2. Geographic Footprint

15.12.3. Product Portfolio

15.12.4. Target Customer Segments

15.12.5. Distribution Strategy

15.12.6. Financial Overview

15.12.7. Certifications

15.12.8. Partnerships

15.12.9. Research and Development Initiatives

15.12.10. Recent Developments

15.12.11. SWOT Snapshot

15.13. Totani Corporation

15.13.1. Overview

15.13.2. Geographic Footprint

15.13.3. Product Portfolio

15.13.4. Target Customer Segments

15.13.5. Distribution Strategy

15.13.6. Financial Overview

15.13.7. Certifications

15.13.8. Partnerships

15.13.9. Research and Development Initiatives

15.13.10. Recent Developments

15.13.11. SWOT Snapshot

15.14. CMD Corporation

15.14.1. Overview

15.14.2. Geographic Footprint

15.14.3. Product Portfolio

15.14.4. Target Customer Segments

15.14.5. Distribution Strategy

15.14.6. Financial Overview

15.14.7. Certifications

15.14.8. Partnerships

15.14.9. Research and Development Initiatives

15.14.10. Recent Developments

15.14.11. SWOT Snapshot

Frequently Asked Questions

Capital equipment such as thermoforming systems, welding and sealing systems, port insertion systems, assembly automation systems, inspection systems, sterilisation preparation systems and end of line packaging equipment used to produce medical bags. This report describes the category strictly as a market for manufacturing equipment, not the medical bags themselves.

The market is estimated at approximately USD 780 Million in 2025 and is projected to reach approximately USD 1,155 Million by 2030, expanding at a compound annual growth rate of roughly 8.2 percent.

Europe accounts for the largest regional concentration, reflecting the density of established equipment engineering capacity, while Asia-Pacific forms the fastest-growing region tied to manufacturing localisation activity.

Rising global demand for IV solution bags, blood bags and dialysis bags is the leading driver, alongside growth in biopharmaceutical manufacturing that is increasing demand for bioprocess single-use bag production lines.

This report covers the capital equipment used to manufacture medical bags. It does not size the medical bags themselves as finished consumable products, which are reported separately in other market categories.

Bioprocess single-use bags form the fastest-growing medical bag type category, tracking the pace of biopharmaceutical manufacturing investment more closely than any other bag type in this report.

Medical device manufacturers, pharmaceutical manufacturers, biopharmaceutical companies, contract manufacturing organisations and hospital product manufacturers are the principal buyer groups identified in this report.

FDA-compliant, EU MDR-compliant, GMP-oriented and ISO 13485-oriented manufacturing systems together govern equipment qualification and specification across the buyer base this report tracks.

Four categories are tracked: manual production systems, semi-automated lines, fully automated manufacturing lines and Industry 4.0 connected production systems, with adoption generally rising alongside bag complexity and production scale.

Inquire Before Buying Request Free Sample Ask For Discount

Medical bag manufacturing equipment separated from general packaging machinery and medical device packaging markets

Medical bag manufacturing equipment is frequently reported inside the much larger packaging machinery market, which spans filling and dosing, labelling, cartoning and general blister and thermoforming equipment across every end-use industry, or inside the medical device packaging market, which sizes finished packaging products such as pouches, boxes and blisters rather than the equipment that makes them. Global packaging machinery is estimated at approximately USD 72.3 billion in 2025, growing at roughly 5.2% CAGR to 2031, with pharmaceutical and healthcare end use expanding faster than the overall market at approximately 6.5% CAGR. This report isolates the narrower equipment category used specifically to manufacture medical bags, thermoforming systems, welding and sealing systems, port insertion systems, assembly automation systems, inspection systems, sterilisation preparation systems and end of line packaging equipment, and excludes both the broader packaging machinery base and the medical bags themselves as finished products.

Derivation from the pharmaceutical and healthcare packaging machinery segment

Applying an estimated share for flexible medical bag forming and converting equipment within the pharmaceutical and healthcare packaging machinery segment, distinct from the larger rigid-container, vial and blister equipment categories that also sit inside that segment, to the segment's own estimated 2025 value produces an annual range of approximately USD 750 to 810 million for medical bag manufacturing equipment specifically.

Bioprocess single-use bag demand weighted separately given its materially faster growth

Single-use bioprocessing, the broader category that includes bioprocess single-use bags, is growing at approximately 14.2% CAGR, a materially faster pace than the pharmaceutical packaging machinery baseline of roughly 6.5%, and IV solution bags and blood bags remain the largest and more slowly growing installed base of demand. Weighting the equipment mix by observed bag-type production share rather than by baseline segment growth alone produces a total range of approximately USD 765 to 795 million, and USD 780 million was adopted near the midpoint.

Forecast basis and its principal sensitivity

The forecast to 2030 assumes global demand for IV solution bags, blood bags, dialysis bags and bioprocess single-use bags continues broadly on recent trends, applying a blended growth rate above the general pharmaceutical packaging machinery baseline to reflect the faster-growing bioprocess single-use bag and Industry 4.0 connected automation categories within this equipment base. Biopharmaceutical manufacturing investment pace is the material sensitivity, since bioprocess single-use bag production equipment demand tracks that investment cycle more closely than any other single category in this report.

Frequently Asked Questions

Capital equipment such as thermoforming systems, welding and sealing systems, port insertion systems, assembly automation systems, inspection systems, sterilisation preparation systems and end of line packaging equipment used to produce medical bags. This report describes the category strictly as a market for manufacturing equipment, not the medical bags themselves.

The market is estimated at approximately USD 780 Million in 2025 and is projected to reach approximately USD 1,155 Million by 2030, expanding at a compound annual growth rate of roughly 8.2 percent.

Europe accounts for the largest regional concentration, reflecting the density of established equipment engineering capacity, while Asia-Pacific forms the fastest-growing region tied to manufacturing localisation activity.

Rising global demand for IV solution bags, blood bags and dialysis bags is the leading driver, alongside growth in biopharmaceutical manufacturing that is increasing demand for bioprocess single-use bag production lines.

This report covers the capital equipment used to manufacture medical bags. It does not size the medical bags themselves as finished consumable products, which are reported separately in other market categories.

Bioprocess single-use bags form the fastest-growing medical bag type category, tracking the pace of biopharmaceutical manufacturing investment more closely than any other bag type in this report.

Medical device manufacturers, pharmaceutical manufacturers, biopharmaceutical companies, contract manufacturing organisations and hospital product manufacturers are the principal buyer groups identified in this report.

FDA-compliant, EU MDR-compliant, GMP-oriented and ISO 13485-oriented manufacturing systems together govern equipment qualification and specification across the buyer base this report tracks.

Four categories are tracked: manual production systems, semi-automated lines, fully automated manufacturing lines and Industry 4.0 connected production systems, with adoption generally rising alongside bag complexity and production scale.

Inquire Before Buying Request Free Sample Ask For Discount